Company intelligence / Profile preview

Migralex

New York, New York, United States
Ownership
Private
Development stage
Other
01

Overview

Migralex is a specialty pharmaceutical company focused on the development and commercialization of over-the-counter treatments for migraine and tension-type headaches. The company's flagship product, Migralex, is a unique formulation that combines aspirin with magnesium oxide to facilitate rapid absorption and reduce gastrointestinal irritation. Founded by Dr. Alexander Mauskop, a renowned neurologist and director of the New York Headache Center, the company aims to provide patients with a fast-acting alternative to traditional oral pain relievers. Migralex is designed to offer the potency of prescription-level relief in an accessible, non-prescription format, specifically targeting the physiological mechanisms of acute migraine attacks.

Therapeutic areas
Neurology
Modalities
Small molecule
Industry
Biotech

Beyond the preview

Go deeper on Migralex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Migralex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call